阶段IIB-IVA宫腺癌和状细胞癌之间的分层预后比较:基于SEER数据库的研究
Huimin Guo1, Songkun Gao2, Weimin Kong1
1Gynecology Department, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, People's Republic of China.
International journal of women's health
|April 10, 2024
概括
宫腺癌的预后往往比状细胞癌更糟. 然而,治疗和阶段显著影响存活率,一些晚期的癌症在用化学辐射治疗时,根据瘤类型没有差异.
科学领域:
- 妇科瘤学 妇科瘤学
- 辐射瘤学 辐射瘤学
- 医学瘤学 医学瘤学
背景情况:
- 宫癌的预后在腺癌和状细胞癌之间有所不同.
- 现有的研究缺乏详细的分期和分组,以进行对比预后.
研究的目的:
- 为了比较宫腺癌和状细胞癌的预后.
- 分析阶段和治疗对生存结果的影响.
主要方法:
- 用于IIB-IVA阶段患者 (2000-2019年) 的SEER数据库.
- 应用倾向性得分匹配 (PSM) 来控制混因素.
- 卡普兰-梅尔曲线和日志等级测试分析了整体生存率 (OS) 和癌症特异性生存率 (CSS).
主要成果:
- 治疗方法与预后有显著的相关性 (P<0.05).
- 对于放射治疗或没有治疗,OS/CSS取决于阶段,而不是瘤类型.
- 在化学辐射中,在PSM后,IIIA/IVA阶段的OS/CSS和IIB阶段的OS独立于组织类型.
结论:
- 治疗和阶段是宫癌存活率的关键决定因素.
- 对于特定的治疗方案 (化学辐射),组织类型可能不会显著改变晚期的预后.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
261
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.1K
相关概念视频
Comparing the Survival Analysis of Two or More Groups
179
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
179
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
